Skip navigation

Intelligence Mission: Berg Finds a Buyer

Investor group BPGbio acquires company’s AI platform, built with $400M in investment, its drug and diagnostic pipelines

By Alex Philippidis –

February 8, 2023

After investing around $400 million to develop its artificial intelligence (AI)-based platform and the company formed to commercialize it, Berg has placed its drug and diagnostic pipelines in the hands of an investor group that has completed its purchase of the 14-year-old company.

CLICK HERE to read more!